20 related articles for article (PubMed ID: 38502867)
1. Silencing HEATR1 Rescues Cisplatin Resistance of Non-Small Cell Lung Cancer by Inducing Ferroptosis via the p53/SAT1/ALOX15 Axis.
Ma X; Gan Y; Mai Z; Song Y; Zhang M; Xia W
Curr Cancer Drug Targets; 2024 May; ():. PubMed ID: 38818906
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of transcription factor TBX5 inhibits the activation of YAP1-TEAD1 pathway to promote ferroptosis in lung cancer cells.
Ma R; Hu K; Dai S; Wang Y
Biochem Biophys Res Commun; 2024 Jul; 718():150037. PubMed ID: 38735135
[TBL] [Abstract][Full Text] [Related]
3. USP14 increases the sensitivity of retinoblastoma to cisplatin by mediating the ferroptosis.
Liu H; Gan Q; Lai Y; Pan Z; Jin Q; Li J; Wang N; Jiao S; Chai Y
Naunyn Schmiedebergs Arch Pharmacol; 2024 May; ():. PubMed ID: 38819674
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitin specific peptidase 3: an emerging deubiquitinase that regulates physiology and diseases.
Wang Y; Shi Y; Niu K; Yang R; Lv Q; Zhang W; Feng K; Zhang Y
Cell Death Discov; 2024 May; 10(1):243. PubMed ID: 38773075
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of METTL14-mediated m
Gong S; Wang S; Shao M
J Mol Med (Berl); 2022 Dec; 100(12):1771-1785. PubMed ID: 36352154
[TBL] [Abstract][Full Text] [Related]
6. ARNTL2 upregulation of ACOT7 promotes NSCLC cell proliferation through inhibition of apoptosis and ferroptosis.
Wang T; Wang K; Zhu X; Chen N
BMC Mol Cell Biol; 2023 Mar; 24(1):14. PubMed ID: 37003979
[TBL] [Abstract][Full Text] [Related]
7. SRSF1 inhibits ferroptosis and reduces cisplatin chemosensitivity of triple-negative breast cancer cells through the circSEPT9/GCH1 axis.
Song X; Wang X; Chen X; Yu Z; Zhou Y
J Proteomics; 2024 Feb; 292():105055. PubMed ID: 38040194
[TBL] [Abstract][Full Text] [Related]
8. Ginkgetin derived from Ginkgo biloba leaves enhances the therapeutic effect of cisplatin via ferroptosis-mediated disruption of the Nrf2/HO-1 axis in EGFR wild-type non-small-cell lung cancer.
Lou JS; Zhao LP; Huang ZH; Chen XY; Xu JT; Tai WC; Tsim KWK; Chen YT; Xie T
Phytomedicine; 2021 Jan; 80():153370. PubMed ID: 33113504
[TBL] [Abstract][Full Text] [Related]
9. LncRNA ITGB2-AS1 promotes cisplatin resistance of non-small cell lung cancer by inhibiting ferroptosis via activating the FOSL2/NAMPT axis.
Chen H; Wang L; Liu J; Wan Z; Zhou L; Liao H; Wan R
Cancer Biol Ther; 2023 Dec; 24(1):2223377. PubMed ID: 37370246
[TBL] [Abstract][Full Text] [Related]
10. USP3: Key deubiquitylation enzyme in human diseases.
Zhang H; Liu W; Wu Y; Chen C
Cancer Sci; 2024 Apr; ():. PubMed ID: 38651282
[TBL] [Abstract][Full Text] [Related]
11. USP3 promotes cisplatin resistance in non-small cell lung cancer cells by suppressing ACOT7-regulated ferroptosis.
Tao R; Liu Z; Zhang Z; Zhang Z
Anticancer Drugs; 2024 Jul; 35(6):483-491. PubMed ID: 38502867
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
